Self-supervised plasma proteomic representations for prospective disease prediction across varying protein availability

Large-scale plasma proteomics offers opportunities to characterize disease susceptibility and improve prospective risk prediction, but transferring proteomic predictors across datasets remains challenging because measured protein sets differ across cohorts, study phases and assay configurations. Here we developed a self-supervised protein-token Transformer that maps the proteins observed in each sample to a fixed-dimensional participant representation, allowing unavailable proteins to be omitted rather than imputed. Using plasma proteomic profiles from 53,014 participants in the UK Biobank Pha